Clinical Trials in Ohio

Showing 9341-9360 of 15,929 trials

PAVES Benchmarking Pilot Study of Daily Disposable Contact Lenses

NCT04032457

The study will compare the short-term clinical performance and wearer and practitioner acceptability in a pilot study of a new-to-market spherical silicone hydrogel daily disposable soft contact lens (SiHyDD) to three (3) benchmark soft daily disposable lenses (DD) and, subsequently, of a new-to-market hydrogel spherical daily disposable (HydDD) soft contact lens to three (3) other hydrogel daily disposable lenses. . The primary outcome variables for this study are subjective comfort and lens preference.

Refractive Errors

Vision Service Plan144 participantsStarted Mar 2019

Atlanta, Georgia, United States • Niles, Illinois, United States • Carmel, Indiana, United States +3 more locations

COMPLETEDNA32 miles

Outcomes of CPM Usage Following Arthroscopic Acetabular Labral Repair

NCT03407612

The purpose of this study is to measure whether CPM (continuous passive motion) usage improves outcomes following arthroscopic hip surgery that includes labral repair. Investigators tested the hypothesis that CPM usage reduces pain levels and pain medication use and improves function in individuals who undergo hip arthroscopy.

Femoro Acetabular ImpingementPain, PostoperativeHip Labral Tear

Ohio State University54 participantsStarted Feb 2013

Columbus, Ohio, United States

COMPLETEDPhase 332 miles

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

NCT02940886

Evaluate safety and efficacy of iron isomaltoside/ferric derisomaltose (Monofer®/Monoferric®) compared with iron sucrose (Venofer®), in subjects diagnosed with IDA.

Iron Deficiency AnaemiaIron Deficiency Anemia

Pharmacosmos A/S1,512 participantsStarted Nov 2016

Birmingham, Alabama, United States • Dothan, Alabama, United States • Guntersville, Alabama, United States +111 more locations

PAVES Benchmarking Pilot Study of Daily Disposable Contact Lenses

Outcomes of CPM Usage Following Arthroscopic Acetabular Labral Repair

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Find Trials by Condition in Ohio

Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL

Losartan to Reverse Sickle Nephropathy

Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD

Single Arm on the Tolerability of Weekly Nab-paclitaxel

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults

Evaluation of Exufiber Ag+ and Other Gelling Fibre Dressings

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy

AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease

Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib